Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Change in Accured Expenses (2016 - 2025)

STRATA Skin Sciences' Change in Accured Expenses history spans 14 years, with the latest figure at $1000.0 for Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 99.95% year-over-year to $1000.0; the TTM value through Sep 2025 reached -$1.1 million, down 141.55%, while the annual FY2024 figure was $2.3 million, 1250.25% up from the prior year.
  • Change in Accured Expenses for Q3 2025 was $1000.0 at STRATA Skin Sciences, up from -$1.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.8 million in Q3 2024 and bottomed at -$1.4 million in Q2 2025.
  • The 5-year median for Change in Accured Expenses is $169000.0 (2025), against an average of $146157.9.
  • The largest annual shift saw Change in Accured Expenses soared 6941.67% in 2021 before it crashed 1544.0% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $821000.0 in 2021, then crashed by 39.59% to $496000.0 in 2022, then fell by 16.53% to $414000.0 in 2023, then tumbled by 64.25% to $148000.0 in 2024, then tumbled by 99.32% to $1000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Change in Accured Expenses are $1000.0 (Q3 2025), -$1.4 million (Q2 2025), and $169000.0 (Q1 2025).